Fidelis Capital Partners’s Johnson & Johnson JNJ Stock Holding History

Fidelis Capital Partners’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14.2M	Buy	55,734 +9,968	+22%	+$2.32M	0.82%	29
2026 Q1	$11.2M	Buy	45,766 +779	+2%	+$181K	0.8%	27
2025 Q4	$9.31M	Buy	44,987 +7,641	+20%	+$1.51M	0.68%	28
2025 Q3	$6.92M	Buy	37,346 +4,615	+14%	+$791K	0.54%	36
2025 Q2	$5.58M	Buy	32,731 +122	+0.4%	+$18.8K	0.51%	37
2025 Q1	$5.04M	Buy	32,609 +2,636	+9%	+$412K	0.54%	38
2024 Q4	$4.55M	Buy	29,973 +1,213	+4%	+$188K	0.46%	48
2024 Q3	$4.77M	Buy	28,760 +2,155	+8%	+$343K	0.57%	32
2024 Q2	$4.23M	Buy	26,605 +2,460	+10%	+$366K	0.6%	34
2024 Q1	$3.82M	Buy	24,145 +6,938	+40%	+$1.1M	0.58%	34
2023 Q4	$2.7M	Buy	17,207 +4,026	+31%	+$617K	0.6%	35
2023 Q3	$2.05M	Buy	13,181 +1,992	+18%	+$329K	0.7%	28
2023 Q2	$1.85M	Buy	11,189 +369	+3%	+$59.6K	0.68%	33
2023 Q1	$1.76M	Buy	10,820 +6,413	+146%	+$1.04M	0.75%	26
2022 Q4	$774K	Buy	+4,407	New	+$761K	0.91%	27

Other funds holding JNJ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Fidelis Capital Partners's JNJ Position: Q2 2026 in Review

Fidelis Capital Partners increased its Johnson & Johnson (JNJ) stake by 22% in Q2 2026, buying an estimated $2.32M and bringing the position to 55,734 shares worth $14.2M. The position accounts for 0.82% of the portfolio, ranked #29.

Fidelis Capital Partners first reported a position in JNJ in Q4 2022 and has held it in 15 quarters since. 4,680 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

Fidelis Capital Partners held 55,734 shares of Johnson & Johnson worth $14.2M as of Q2 2026.
Fidelis Capital Partners bought 9,968 Johnson & Johnson shares in Q2 2026, an estimated $2.32M.
Johnson & Johnson made up 0.82% of Fidelis Capital Partners's portfolio in Q2 2026, its #29 holding.
Fidelis Capital Partners first reported a position in Johnson & Johnson in Q4 2022 and has held it in 15 quarters since.
4,680 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Fidelis Capital Partners's 13F filing for Q2 2026, filed 13 Aug 2026.